1. Volume 152, Issue 1, Pages 300-301 (January 2017)
Sofosbuvir and Daclatasvir Anti–Viral Therapy Fails to Clear HEV Viremia and Restore Reactive T Cells in a HEV/HCV Co-Infected Liver Transplant Recipient 
Mhairi C. Donnelly 
Gastroenterology 
Volume 152, Issue 1, Pages (January 2017)
DOI: /j.gastro
Copyright © 2017 AGA Institute Terms and Conditions

2. Figure 1
(A) Trend on hepatitis E virus RNA and hepatitis C virus PCR during sofosbuvir and daclatasvir therapy. (B) Change in percentage of CD4+ naïve cells, central memory (TCM) cells, effector memory (TEM) cells and terminal effector (TTE) cells pre- and during sofosbuvir and daclatasvir therapy. (C) Change in percentage of CD8+ naïve cells, central memory (TCM) cells, effector memory (TEM) cells and terminal effector (TTE) cells pre- and during sofosbuvir and daclatasvir therapy.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2017 AGA Institute Terms and Conditions